Grass pollen sublingual immunotherapy and paediatric allergic rhinitis: A patient-oriented decision

• Stefano Miceli Sopo ^[1] ; Andrea Battista ^[1] ; Monica Greco ^[1] ; Serena Monaco ^[1]
  1. [1] Agostino Gemelli Hospital, Roma
• Localización: Allergologia et immunopathologia: International journal for clinical and investigate allergology and clinical immunology, ISSN-e 1578-1267, ISSN 0301-0546, Vol. 44, Nº. 4, 2016, págs. 382-386
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Guidelines and systematic review report that allergen immunotherapy (AIT) is, in general, effective in the treatment of allergic rhinitis. However, experts suggest not generalising the results of different clinical studies: for example, it would not be advisable to translate the results found in an adult population to a paediatric population or the results on the efficacy of AIT against a specific allergen to the AIT against a different allergen. Moreover, according to Evidence Based Medicine (EBM), clinical decisions are individualised and should derive from the “integration of best research evidence with clinical expertise and patient values”. Taking into account the high specificity of the AIT and EBM principles, we tried to answer the question on how advisable it is to prescribe the AIT for the management of grass allergic rhinitis in children. To do this, we revised the scientific literature in order to solve a specific case scenario.